Latest Banking News

DigitalX Limited reported a 15% revenue increase in Q4 2024, driven by staking activities and performance fees, alongside a $10.3 million private placement and strategic Solana investment. The DigitalX Bitcoin ETF surpassed $50 million in funds under management, delivering a 67.4% quarterly return.

Meteoric Resources NL has reported a significant update to its Caldeira Rare Earth Project, highlighting improved financial metrics and exceptional drilling results that reinforce its position as a low-cost rare earths producer.

Metal Bank Limited reported a net cash outflow of $161,000 for the December 2024 quarter, maintaining $1.2 million in cash reserves supported by recent financing activities.

Metal Bank Limited reports significant progress across its Australian and MENA projects, including a strategic review of its Livingstone Gold Project and new exploration rights in Saudi Arabia and Jordan, supported by a fully subscribed $1.56 million entitlement offer.

MONEYME reports a 54% surge in loan originations and a $1.4 billion loan book in 2Q25, underpinned by fresh growth capital and a strategic shift to secured lending.

Propell Holdings has reported its first half-year cash profit since its 2021 ASX listing, driven by loan book growth and new product launches, despite a Q2 operating cash outflow.

VanEck Investments Limited has announced final dividends for a suite of its Australian and global bond ETFs, with payments scheduled for mid-February 2025. Investors are advised to note the ex-dividend dates and dividend reinvestment plan details.

Vulcan Energy has marked a pivotal quarter with major capital raises, strategic partnerships, and the commencement of Europe’s first fully integrated battery-quality lithium hydroxide production.

GreenHy2 Limited reports a slight cash decline but strengthens its foothold in renewable energy with key partnerships and strategic pivots in hydrogen storage technology.

Control Bionics has delivered its strongest US sales quarter in years, nearing US$1 million in revenue, while broadening its market footprint with new commercial agreements and cost optimizations.

Little Green Pharma reports a robust 75% revenue increase to $9.5 million for December quarter, driven by strong European market growth and strategic product launches.

St Barbara has secured A$100 million to fast-track its Simberi Sulphides project, aiming to bring forward production by up to five months, even as Q2 gold output fell short of expectations due to operational challenges.